Share with your friends

KPMG’s Chief Medical Advisor commits to the fight against antibiotic resistance

KPMG commits to the fight against antibiotic resistance

Chief Medical Advisor for KPMG, Professor Hilary Thomas, has publicly declared her dedication to helping tackle the global increasing resistance to antibiotics.


Also on

Professor Thomas, along with Members of the Global Chief Medical Officers’ (CMO) Network, have signed a pledge on antimicrobial resistance that urges companies to support the appropriate use of antibiotics, as resistance is on the rise. This action comes as Public Health England (PHE) launches a campaign to tackle the crisis.

Antimicrobial resistance – when bacteria no longer responds to the antibiotics designed to kill them – is one of the biggest threats to global health. It can lead to longer hospital stays, higher medical costs and increased rates of mortality.

Around half of all antibiotics are prescribed for the wrong reason, which is speeding up resistance. The pledge, includes several achievable actions that can change everyday behaviour to make a real impact and better support the health and wellbeing of those around us.

In her role at KPMG, Professor Thomas’s clients include major global pharmaceutical companies and NHS hospitals. Professor Thomas commented: “The threat of antibiotic resistance is massive. It’s so important that I use my position to help influence the companies and organisations I work with on the appropriate use of antibiotics. Unlike most drugs, we do not want to use antibiotics except when absolutely essential and appropriate. Over-use risks a future where we no longer have treatments for life threatening infections returning to a situation akin to the pre-antibiotic era.

The CMO Network is supported by Bupa. Dr Paul Zollinger-Read, Bupa’s Chief Medical Officer, said: “Modern medicine relies on antimicrobials – and antibiotics in particular. They treat life-threatening infections and are vital to many medical advances, from basic surgery, to heart transplants and chemotherapy. But, as bacteria develop resistance, antibiotics are starting to fail.

Actions encouraged in the pledge include not requesting antibiotics when clinicians advise they are not needed, and not sharing or using leftover antibiotics. It also covers preventing infection through regularly washing hands, keeping vaccinations up to date and preparing food hygienically.


Notes to editors:

Professor Hilary Thomas is an NHS oncologist by background.


For further information please contact:

Helen Jackson, KPMG corporate communications

T : 0118 373 1479

E :


About KPMG

KPMG LLP, a UK limited liability partnership, operates from 22 offices across the UK with approximately 13,500 partners and staff. The UK firm recorded a revenue of £2.07 billion in the year ended 30 September 2016. KPMG is a global network of professional firms providing Audit, Tax, and Advisory services. It operates in 152 countries and has 189,000 professionals working in member firms around the world. The independent member firms of the KPMG network are affiliated with KPMG International Cooperative ("KPMG International"), a Swiss entity. Each KPMG firm is a legally distinct and separate entity and describes itself as such.

© 2021 KPMG LLP a UK limited liability partnership and a member firm of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.

For more detail about the structure of the KPMG global organisation please visit

Connect with us


Want to do business with KPMG?


loading image Request for proposal

Save, Curate and Share

Save what resonates, curate a library of information, and share content with your network of contacts.

Sign up today